At 12 months, there was a statistically significant 0.12-point (95% CI, 0.00–0.24, p = 0.048) improvement in the EQ-5D score in the PAF cohort; however, the 0.04-point (95% CI, -0.01–0.09, p = 0.08) improvement in the PsAF cohort did not reach statistical significance (Table 5 ).
← all excerpts
Safety, efficacy, and quality of life outcomes of pulsed field ablation in Japanese patients with atrial fibrillation: results from the PULSED AF trial.
1
—
—